Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18.62	23.59	30.41	33.46	50.01	64.4
Short-Term Investments	0.51	0.56	0.5	10.47	0.53	0.01
Cash & Short-Term Investments	19.12	24.15	30.91	43.93	50.54	64.41
Cash Growth	-31.61%	-21.86%	-29.64%	-13.09%	-21.53%	31317.56%
Accounts Receivable	4.02	4.86	3.57	4.13	2.32	0.05
Other Receivables	0.62	0.51	0.24	-	-	0.21
Receivables	4.64	5.37	3.81	4.13	2.32	0.25
Prepaid Expenses	0.3	0.19	0.59	1.75	1.1	1.95
Total Current Assets	24.18	29.71	35.31	49.8	53.96	66.61
Property, Plant & Equipment	1.77	1.99	2.15	1.06	0.3	0.18
Long-Term Investments	5.13	3.75	4.8	4.95	4.53	0.01
Other Intangible Assets	3.96	1.76	3.83	1.81	1.85	1.51
Long-Term Accounts Receivable	2.01	2.05	1.59	1.31	1.71	-
Long-Term Deferred Charges	-	2.08	-	1.68	1.09	0.87
Other Long-Term Assets	-	-	-	0.12	-	-
Total Assets	37.05	41.34	47.68	60.73	63.44	69.18
Accounts Payable	2.33	3.17	3.2	2.3	2.62	1.6
Accrued Expenses	0.25	0.26	0.12	0.07	0.08	0.03
Short-Term Debt	0.08	-	-	-	-	0.41
Current Portion of Long-Term Debt	-	0.05	-	-	8.62	-
Current Portion of Leases	0.25	0.28	0.24	0.14	0.07	0.05
Current Income Taxes Payable	0.04	-	-	-	0.35	0.05
Current Unearned Revenue	-	-	0.01	-	-	-
Other Current Liabilities	3.38	3.41	3.2	3.26	3.25	0.01
Total Current Liabilities	6.32	7.16	6.76	5.77	14.98	2.13
Long-Term Debt	-	0.05	-	-	-	7.89
Long-Term Leases	1.32	1.44	1.51	0.75	0.11	0.11
Other Long-Term Liabilities	0.52	0.54	0.34	0.3	0.3	-
Total Liabilities	8.16	9.19	8.61	6.82	15.39	10.12
Common Stock	0.14	0.14	0.14	0.14	0.13	0.13
Additional Paid-In Capital	121.51	121.51	121.51	121.51	103.69	103.69
Retained Earnings	-90.03	-86.47	-80.76	-65.38	-54.81	-43.23
Comprehensive Income & Other	-2.74	-3.04	-1.82	-2.36	-0.96	-1.54
Total Common Equity	28.89	32.14	39.07	53.91	48.06	59.06
Shareholders' Equity	28.89	32.14	39.07	53.91	48.06	59.06
Total Liabilities & Equity	37.05	41.34	47.68	60.73	63.44	69.18
Total Debt	1.65	1.82	1.75	0.89	8.79	8.45
Net Cash (Debt)	17.47	22.34	29.15	43.04	41.75	55.96
Net Cash Growth	-32.99%	-23.39%	-32.27%	3.09%	-25.39%	-
Net Cash Per Share	0.64	0.80	1.04	1.58	1.62	2.56
Filing Date Shares Outstanding	27.35	28	28	28	25.83	25.83
Total Common Shares Outstanding	27.35	28	28	28	25.83	25.83
Working Capital	17.86	22.55	28.55	44.03	38.98	64.48
Book Value Per Share	1.06	1.15	1.40	1.93	1.86	2.29
Tangible Book Value	24.93	30.39	35.24	52.1	46.2	57.55
Tangible Book Value Per Share	0.91	1.09	1.26	1.86	1.79	2.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.